Literature DB >> 18767932

Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism.

Karin Weber1, Claudia Bergow, Sieglinde Hirmer, Christiane Schüler, Reinhold G Erben.   

Abstract

Cell proliferation and PTH secretion in the parathyroid gland are known to be regulated by vitamin D and extracellular calcium. Here, we examined the vitamin D-independent effects of correction of extracellular calcium in an adult-onset secondary hyperparathyroidism (sHPT) model, using mice with a nonfunctioning vitamin D receptor (VDR). Wildtype and homozygous VDR mutant mice were kept on a rescue diet (RD) containing 2% calcium (Ca), 1.25% phosphorus (P), and 20% lactose until they were 4 mo or 1 yr of age. Subsequently, 4-mo-old mice were switched to a challenge diet (CD) containing the following: 0.5% Ca, 0.4% P, and 0% lactose. After 2 mo on the CD, groups of VDR mutant mice were either fed CD, a normal mouse chow with 0.9% Ca, 0.7% P, and 0% lactose, or the RD for another 3 mo. Feeding the RD protected VDR mutants against sHPT over 1 yr, showing that vitamin D is not essential for long-term control of the function and proliferation of parathyroid cells. When 4-mo-old VDR mutants were switched from the RD to the CD for 2 mo, they developed severe sHPT associated with hypertrophy and hyperplasia of parathyroid glands and profound bone loss. Subsequent feeding of the RD during a 3-mo therapy phase fully corrected sHPT, reduced chief cell proliferation, and reduced maximum parathyroid gland area by 25% by cell atrophy. There was no evidence of RD-induced chief cell apoptosis. We conclude that signaling by the calcium-sensing receptor regulates chief cell function and size in the absence of signaling through the VDR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18767932     DOI: 10.1359/jbmr.0080904

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.

Authors:  Carmen Streicher; Ute Zeitz; Olena Andrukhova; Anne Rupprecht; Elena Pohl; Tobias E Larsson; Wilhelm Windisch; Beate Lanske; Reinhold G Erben
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

2.  Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).

Authors:  Francesca Giusti; Luisella Cianferotti; Giorgio Gronchi; Federica Cioppi; Laura Masi; Antongiulio Faggiano; Annamaria Colao; Piero Ferolla; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-07-30       Impact factor: 3.633

3.  Vitamin D endocrine system and osteocytes.

Authors:  Beate Lanske; Michael J Densmore; Reinhold G Erben
Journal:  Bonekey Rep       Date:  2014-02-05

4.  Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo.

Authors:  René Anour; Olena Andrukhova; Eva Ritter; Ute Zeitz; Reinhold G Erben
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

5.  Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice.

Authors:  Olena Andrukhova; Christiane Schüler; Claudia Bergow; Alexandra Petric; Reinhold G Erben
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-11       Impact factor: 5.555

6.  No Role of Osteocytic Osteolysis in the Development and Recovery of the Bone Phenotype Induced by Severe Secondary Hyperparathyroidism in Vitamin D Receptor Deficient Mice.

Authors:  Barbara M Misof; Stéphane Blouin; Jochen G Hofstaetter; Paul Roschger; Jochen Zwerina; Reinhold G Erben
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.